BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 32181485)

  • 21. Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway.
    Li R; Luo S; Zhang D
    Gene; 2020 Sep; 754():144811. PubMed ID: 32464246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.
    Liu H; Chen D; Bi J; Han J; Yang M; Dong W; Lin T; Huang J
    Aging (Albany NY); 2018 Oct; 10(10):2606-2623. PubMed ID: 30312173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence.
    Bi J; Liu H; Dong W; Xie W; He Q; Cai Z; Huang J; Lin T
    Mol Cancer; 2019 Sep; 18(1):133. PubMed ID: 31481066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
    Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
    Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
    Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
    Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel circRNA circ_0045881 inhibits cell proliferation and invasion by targeting mir-214-3p in triple-negative breast cancer.
    Ren J; Chen W; Zhou Y; Sun J; Jiang G
    BMC Cancer; 2024 Mar; 24(1):278. PubMed ID: 38429642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression.
    Su H; Tao T; Yang Z; Kang X; Zhang X; Kang D; Wu S; Li C
    Mol Cancer; 2019 Feb; 18(1):27. PubMed ID: 30782157
    [TBL] [